Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 14, 2007
Podcast of the "Proton Therapy in Practice" from the 2007 American Society for Therapeutic Radiology And Oncology annual meeting held this year in Los Angeles California. International cancer experts give you an exclusive opportunity to learn and share the information on the most recent developments in Proton Therapy. Tune in now to experience these presentations by our thought leaders in Proton Therapy.
Overview of Rationale and Indications for Proton Therapy
Nancy P. Mendenhall, MD Professor and Medical Director of the University of Florida Proton Therapy Institute and Associate Chair of the Department of Radiation Oncology-Jacksonville (Gainsville, FL)
Physics and Challenges of Proton Therapy
Jatinder Palta, PhD: Professor and Chief of Physics in the Department of Radiation Oncology at the University of Florida Proton Therapy Institute (Gainsville, FL)
Proton Therapy in Pediatric CNS Malignancies
Torunn I. Yock, MD, MCH: Assistant Professor in the Department of Radiation Oncology at the Francis H. Burr Proton Therapy Center, Massachusetts General Hospital and Harvard medical School (Boston, MA)
Proton Therapy in Lung Cancer
Joe Y. Chang, MD, PhD: Assistant Professor in the Department of Radiation Oncology and Clinical Chief, Thoracic Radiation Oncology at the University of Texas M.D. Anderson Cancer Center (Houston, TX)
Proton Therapy in Prostate Cancer
Carlos Vargas, MD: Assistant Professor in the Department of Radiation Oncology at the University of Florida Proton Therapy Institute (Gainesville, FL)
Ongoing and Future Clinical Investigation
James M. Metz, MD: Assitant Professor and Chief of Clinical Operations in the Department of Radiation Oncology and Editor-in-Chief, OncoLink at the Hospital of the University of Pennsylvania
Techinical Development in Proton Therapy
Harald Paganetti, PhD: Associate Professor in the Department of Radiation Oncology at the Francis H. Burr Proton Therapy Center, Massachusetts General Hospital and Harvard medical School (Boston, MA)
You may also view the videos in Flash.
Nov 22, 2014 - Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago.
Apr 18, 2012
Jun 14, 2013
May 29, 2014